Integra LifeSciences IART Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
As of June 30, 2026, the short-term portion of the contract liability of $11.7 million, representing 54% of unsatisfied or partially unsatisfied performance obligations, is expected to be recognized as revenue within 12 months and is included in current liabilities in the consolidated balance sheet. The long-term portion of $10.0 million, representing the remaining balance to be recognized thereafter, is included in other liabilities in the consolidated balance sheet.
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's contract liabilities, non-current?
- Integra LifeSciences (IART) reported contract liabilities, non-current of $10M in Q2 2026.
- How has Integra LifeSciences's contract liabilities, non-current changed year-over-year?
- Integra LifeSciences's contract liabilities, non-current decreased by 9.1% year-over-year, from $11M to $10M.
Ask your AI about Integra LifeSciences's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
